RAPID_REVIEW_H7N9_27MayFINALisbn

…period has been estimated to be seven days. b. Early signs and symptoms were most commonly those of an influenza-like illness. Severe illness has been characterized by rapid deterioration to…

2022-11-23_Sequencing_Winnipeg

…of May 2022 and high signals have been detected in samples collected up to November 6, 2022. Winnipeg South End The plot shows a high presence of BA.1 until late…

Disease Debriefs

…has risen significantly in recent years. In 2019, for example, there were 53 cases of congenital syphilis, the highest number of cases ever reported in Canada. Case counts have risen…

2022-10-25_Modelling_Report_WPG

forecasting that describes infections of COVID-19 in the community and also considers how infected people shed the COVID- 19 virus into the sewer systems and how that shed virus signal…

Effectiveness of seasonal influenza vaccines against influenza A (H1N1) infection in post-pandemic seasons: Highlights of a systematic review

Introduction Following the 2009 pandemic, pre-pandemic influenza A/H1N1 strains were almost entirely displaced by the A(H1N1)pdm09 virus pandemic strain, which continues to cause significant seasonal epidemics. Starting in the 2010/11…

Hand, Foot, and Mouth Disease (HFMD)

…are rare like loss of a fingernail or toenail, headache, stiff neck, or back pain (signs of meningitis), drowsy or paralysis (signs of encephalitis) Pregnant women should contact their healthcare…

Tyler Stitt

…involved in research design and planning, rapid, targeted literature reviews, systematic literature reviews, and survey design and analysis. He recently assisted with the facilitation of a workshop at the Food…

PP_36_EN

…cost saving than a dual-RPOCT (TT and NTT) strategy in a high prevalence setting but that the dual-RPOCT strategy may significantly reduce overtreatment (Owusu- Edesei, 2011). No cost-effectiveness data are…

PP_36_EN

…cost saving than a dual-RPOCT (TT and NTT) strategy in a high prevalence setting but that the dual-RPOCT strategy may significantly reduce overtreatment (Owusu- Edesei, 2011). No cost-effectiveness data are…